Medxtractor updates the SHAMAN psychedelics project and extractor operations
Calgary, Alberta – January 19, 2021.
For Immediate Release – Medxtractor Corp. (“MXT”) updates the SHAMAN psychedelics project and extractor operations.
The Company reports that the initial specification for the SHAMAN division’s psychedelics project has progressed to the point that the proof-of-concept (“POC”) phase can begin. Jim Durward, President, states: “We have recently acquired EEG equipment and engaged a very experienced database programmer to initiate the POC. I have previously worked with the programmer on a very complex multi-year image analysis and pattern recognition system and I am completely confident in his ability to meet SHAMAN’s needs. At this point I believe we are ahead of schedule and under budget.”
The Company further reports that the extractor division is performing well with December, 2020 extractor Unit sales having increased by more than 100% over December, 2019.”
Mr. Durward adds: “This trend is continuing with January 2021 unit sales having already exceeded January 2020 unit sales. I believe this trend is due to increased certainty around both the US political situation going forward, Covid-19 vaccine availability, and a general trend toward cannabis legalization worldwide.”
ABOUT MEDXTRACTOR CORP:
The Corporation is a Calgary-based company that generates technologically-based solutions. With installations all over the world, its patented craft-scale bio-extractors are used to extract compounds from a variety of botanical materials. The SHAMAN division is focusing on applying machine learning to predict potential benefits associated with the use of psychedelic drugs within the mental health misdiagnosis problem.
FOR FURTHER INFORMATION, PLEASE CONTACT:
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: [email protected]
Website: www.medxtractor.com or www.shaman-ai.com
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.